Latest SRNE reports update at 2023-05-15: 2023-Q12022-Q42022-Q1
Sorrento Therapeutics logo
Sorrento Therapeutics SRNE
$ 0.27 -29.58%

Sorrento Therapeutics Financial Ratios 2011-2024 | SRNE

Annual Financial Ratios Sorrento Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.4 -9.7 -1.8 -1.1 56.9 -4.3 -4.2 -7.8 -6.9 -14.7 -16.9

P/S

-4679.0 72.8 16.4 10.9 3.4 32.4 42.2 70.4 329.3 122.1 103.1

EPS

-1.4 -1.3 -2.2 -1.9 0.1 -1.2 -1.2 -1.3 -1.5 -0.0 -0.0

EV (Enterprise Value)

1.17 B 3.25 B 1.02 B 488 M 724 M 497 M 357 M 230 M 146 M 66.8 M 51.5 M

EBITDA per Share

-1.32 -0.859 -1.44 -1.19 0.775 -1.17 -1.32 -1.21 -0.989 -0.4 -0.311

EV/EBITDA

-3.0 -15.0 -3.8 -2.4 9.3 -3.9 -3.4 -6.5 -8.4 -14.5 -16.6

PEG

0.02 -0.24 0.12 0.0 0.51 -1.79 -0.92 -0.71 0.04 0.15 0.57

P/B

7.5 17.6 6.6 1.1 2.6 3.3 1.3 2.5 2.3 11.5 13.0

P/CF

-2.1 -14.8 -2.8 -1.9 -4.7 -3.4 -4.2 -9.2 -8.7 -16.4 -14.4

ROE %

-543.92 -180.72 -371.64 -97.17 4.58 -76.12 -31.56 -31.88 -32.80 -78.18 -76.89

ROA %

-61.65 -55.70 -52.38 -32.61 2.12 -15.17 -13.34 -24.49 -23.67 -71.45 -70.84

ROCE %

-509.79 -45.87 -44.12 -23.02 14.59 -18.40 -15.99 -26.16 -18.00 -78.30 -77.03

Current Ratio

1.1 0.9 0.6 2.9 0.4 1.2 4.6 7.7 6.0 9.0 9.9

DSO

-49566.1 141.5 168.5 75.1 9.4 133.7 208.2 69.9 312.7 49.9 42.2

DIO

- 67.2 100.3 - - - - - - - -

DPO

- 907.2 824.1 714.3 917.0 3727.4 250.6 295.9 177064.5 - -

Operating Cycle

-49566.1 208.8 268.8 75.1 9.4 133.7 208.2 69.9 312.7 - -

Cash Conversion Cycle

-49566.1 -698.4 -555.3 -639.3 -907.6 -3593.8 -42.4 -226.0 -176751.7 - -

All numbers in USD currency

Quarterly Financial Ratios Sorrento Therapeutics

2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.26 - -0.2 -0.54 -0.12 -0.47 -0.4 -0.57 0.01 -0.27 -0.33 -0.36 -0.36 -0.41 -0.49 -0.46 -0.88 -0.41 -0.4 -0.73 -0.38 0.6 -0.03 -0.2 -0.45 -0.3 0.24 -0.93 -0.41 -0.62 -0.03 -0.3 -0.29 -0.26 -0.27 -0.33 -0.44 - -0.24 -0.35 -0.2 - -0.1 -0.08 - - - - -

EBITDA per Share

-0.19 - -0.22 -0.28 -0.31 - -0.31 -0.33 -0.29 - -0.3 -0.19 -0.22 - -0.34 -0.36 -0.98 - -0.36 -0.24 -0.36 - 1.33 -0.15 -0.43 - -0.17 -0.94 -0.57 - -905 -0.25 -0.26 - -0.17 -254 -395 - -0.19 -0.33 -0.2 - -0.09 -0.07 - - - - -

ROE %

-186.29 -247.65 -431.04 -454.32 -382.51 -363.42 -223.32 -182.97 -140.20 -180.72 -217.36 -248.45 -273.60 -371.64 -315.47 -256.10 -219.13 -97.17 -49.13 -27.57 0.58 4.58 -42.01 -21.12 -68.12 -76.12 -72.13 -92.63 -46.07 -33.71 -23.21 -29.56 -29.79 -31.88 -29.08 -27.11 -52.13 -70.62 -148.80 -221.96 -267.34 -170.99 -187.67 -126.17 -73.83 -58.78 -16.68 -25.84 -16.26

ROA %

-94.17 -54.04 -74.83 -76.19 -62.87 -57.71 -50.27 -50.03 -43.14 -55.70 -53.62 -49.49 -45.16 -52.38 -49.09 -45.12 -46.77 -32.61 -13.41 -6.31 2.24 2.12 -13.56 -9.12 -16.62 -15.17 -18.47 -22.70 -15.10 -14.24 -12.51 -17.61 -20.39 -24.49 -22.10 -20.35 -38.05 -50.96 -122.41 -190.23 -238.01 -156.26 -171.63 -115.55 -67.91 -54.16 -15.37 -23.81 -14.98

ROCE %

-168.46 -217.44 -294.64 -288.84 -255.85 -168.17 -218.49 -191.61 -166.31 -105.36 -173.16 -190.64 -225.82 -288.61 -311.48 -266.55 -216.01 -51.95 -3.39 68.05 74.85 30.13 14.83 -49.04 -98.16 -98.67 -123.22 -132.47 -83.86 -38.82 -45.38 -27.39 -27.48 -22.99 -27.94 -26.33 -26.04 -15.77 -35.84 -50.95 -59.13 -49.95 -66.67 -63.32 -73.96 -58.89 -16.72 -25.88 -16.30

Current Ratio

0.8 1.0 1.3 1.3 1.4 1.1 1.2 1.3 1.6 1.4 1.4 1.4 1.4 1.1 1.1 1.1 1.1 1.5 1.5 1.5 1.5 1.9 1.9 1.9 1.9 1.3 1.3 1.3 1.3 1.7 1.7 1.7 1.7 4.3 4.3 4.3 - - - - - - - - - - - - -

DSO

143.2 - 35988.6 31296.8 107.7 122.7 10819.5 -80353.9 -3464.3 123.0 -2499.9 -301.1 -2458.5 91.1 168.6 121.1 83.5 40.2 67.9 89.4 44.1 9.9 1.6 43.2 36.6 38.5 69.0 171.6 120.0 61.6 74.7 70.2 76.3 83.7 52.4 86.2 52.6 - 433.2 253.2 161.3 - - - - - - - -

DIO

- - - - - - - - - - - - - - - 93.5 123.8 - 121.5 215.7 100.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - 768.4 819.3 - 579.1 1028.4 825.8 - 833.5 1108.3 780.1 - 1808.0 2561.8 1222.7 - 202.3 389.1 268.5 - 286.7 296.3 308.7 - - - - - - - - - - - -

Operating Cycle

143.2 - 35988.6 31296.8 107.7 122.7 10819.5 -80353.9 -3464.3 123.0 -2499.9 -301.1 -2458.5 91.1 168.6 214.6 207.2 40.2 189.4 305.1 145.0 9.9 1.6 43.2 36.6 38.5 69.0 171.6 120.0 61.6 74.7 70.2 76.3 83.7 52.4 86.2 52.6 - 433.2 253.2 161.3 - - - - - - - -

Cash Conversion Cycle

143.2 - 35988.6 31296.8 107.7 122.7 10819.5 -80353.9 -3464.3 123.0 -2499.9 -301.1 -2458.5 91.1 168.6 -553.8 -612.1 40.2 -389.8 -723.3 -680.8 9.9 -831.9 -1065.1 -743.6 38.5 -1739.0 -2390.2 -1102.7 61.6 -127.6 -318.9 -192.1 83.7 -234.4 -210.1 -256.0 - 433.2 253.2 161.3 - - - - - - - -

All numbers in USD currency